Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin.

scientific article

Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/AJH.23960
P932PMC publication ID4409501
P698PubMed publication ID25639727

P50authorSara K. VeselyQ47704315
Deirdra R TerrellQ56477350
Brian CurtisQ68181804
P2093author name stringJames N George
Richard H Aster
Daniel W Bougie
Jessica A Reese
P2860cites workQuinine-induced disseminated intravascular coagulationQ28334464
Cocaine-induced acute renal failure, hemolysis, and thrombocytopenia mimicking thrombotic thrombocytopenic purpuraQ28378388
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) following treatment with deoxycoformycin in a patient with cutaneous T-cell lymphoma (Sezary syndrome): A case reportQ33329687
Occult quinine-induced thrombocytopeniaQ33335490
Immune thrombocytopenia resulting from sensitivity to metabolites of naproxen and acetaminophenQ33337591
Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomesQ33340232
Spontaneous reports of thrombocytopenia in association with quinine: clinical attributes and timing related to regulatory actionQ33344074
ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patientsQ33346954
Quinine induced HUS-TTP: an unusual presentationQ33358133
Quinine/quinidine-induced thrombocytopenia: a great imitatorQ33358724
Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods.Q33389987
Thrombotic thrombocytopenic purpura (TTP)-like illness associated with intravenous Opana ER abuse--Tennessee, 2012.Q33405202
Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical featuresQ33408146
Thrombotic microangiopathy and acute kidney injury associated with intravenous abuse of an oral extended-release formulation of oxymorphone hydrochloride: kidney biopsy findings and report of 3 casesQ33413338
Syndromes of thrombotic microangiopathyQ33417044
Drug-induced thrombotic microangiopathy: a systematic review of published reportsQ33418784
Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: clinical and serological findings in nine patients and review of literatureQ33491281
Drug-induced thrombocytopenia: a systematic review of published case reportsQ33504761
Adverse drug reactions: definitions, diagnosis, and managementQ40739350
Thrombotic microangiopathy associated with gemcitabine: rare but real.Q45978337
Drug-induced immune thrombocytopeniaQ80768388
P433issue5
P921main subjectOklahomaQ1649
P304page(s)406-410
P577publication date2015-02-25
P1433published inAmerican Journal of HematologyQ4744246
P1476titleDrug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin
P478volume90

Reverse relations

cites work (P2860)
Q96304836An Update in Drug-Induced Thrombotic Microangiopathy
Q33705135Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab
Q33431057Carfilzomib: A cause of drug associated thrombotic microangiopathy
Q58727886Complement-mediated thrombotic microangiopathy associated with lupus nephritis
Q33429589Diversity and severity of adverse reactions to quinine: A systematic review
Q58704884Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
Q58805821Drug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians
Q98292974Drug-Induced Thrombotic Microangiopathy Resulting in ESRD
Q64907238Drug-Induced Thrombotic Microangiopathy due to Cumulative Toxicity of Ixazomib.
Q92134406Eculizumab in chemotherapy-induced thrombotic microangiopathy
Q46032407Effective treatment of chemotherapy induced atypical Haemolytic Uraemic Syndrome: a case series of 7 treated patients.
Q30276550Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue
Q89373702Haemolytic uraemic syndrome
Q41070320Hemolytic anemia
Q48299809Ixazomib-induced thrombotic microangiopathy.
Q92924160Late Presentation of Carfilzomib Associated Thrombotic Microangiopathy
Q47841893Long-term outcomes of health-related quality of life following diverse thrombotic microangiopathy syndromes.
Q50224262Neurological variability in chemotherapy-induced posterior reversible encephalopathy syndrome associated with thrombotic microangiopathy: Case reports and literature review
Q64933058Prasugrel and Acquired Thrombotic Thrombocytopenic Purpura Associated with ADAMTS13 Activity Deficiency.
Q33432949Proteasome inhibitor associated thrombotic microangiopathy
Q26739684Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting
Q90601264Thrombotic Thrombocytopenic Purpura Associated with Pazopanib
Q41247102Thrombotic microangiopathy associated with Valproic acid toxicity
Q42368351Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab.
Q55346941Thrombotic thrombocytopenic purpura possibly triggered by Graves' disease.